<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>7674924</pmcid><all-ids><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmid">33250836</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmc">7674924</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="doi">10.3389/fneur.2020.01032</article-id></all-ids><extracted-table><table-id>T1</table-id><table-label>Table 1</table-label><table-caption>Demographic and Clinical Data of the Two Study Groups.</table-caption><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="T1" position="float"><label>Table 1</label><caption><p>Demographic and Clinical Data of the Two Study Groups.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><bold>Variable</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>ESRD patients</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>Healthy controls</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold><italic>p</italic>-value</bold></th></tr><tr><th rowspan="1" colspan="1"/><th valign="top" align="center" rowspan="1" colspan="1"><bold>(<italic>n</italic> = 32)</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>(<italic>n</italic> = 45)</bold></th><th rowspan="1" colspan="1"/></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Age (years)</td><td valign="top" align="center" rowspan="1" colspan="1">44.4 ± 15.0</td><td valign="top" align="center" rowspan="1" colspan="1">38.7 ± 13.1</td><td valign="top" align="center" rowspan="1" colspan="1">0.080<xref ref-type="table-fn" rid="TN2"><sup>b</sup></xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Sex (male/female)</td><td valign="top" align="center" rowspan="1" colspan="1">17/15</td><td valign="top" align="center" rowspan="1" colspan="1">23/22</td><td valign="top" align="center" rowspan="1" colspan="1">0.862<xref ref-type="table-fn" rid="TN1"><sup>a</sup></xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Education (years)</td><td valign="top" align="center" rowspan="1" colspan="1">12.3 ± 2.7</td><td valign="top" align="center" rowspan="1" colspan="1">12.9 ± 3.4</td><td valign="top" align="center" rowspan="1" colspan="1">0.404<xref ref-type="table-fn" rid="TN2"><sup>b</sup></xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Dialysis duration (month)</td><td valign="top" align="center" rowspan="1" colspan="1">12.3 ± 12.2</td><td valign="top" align="center" rowspan="1" colspan="1">–</td><td valign="top" align="center" rowspan="1" colspan="1">–</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">creatinine (μmol/L)</td><td valign="top" align="center" rowspan="1" colspan="1">642.3 ± 332.6</td><td valign="top" align="center" rowspan="1" colspan="1">–</td><td valign="top" align="center" rowspan="1" colspan="1">–</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Urea (mmol/L)</td><td valign="top" align="center" rowspan="1" colspan="1">22.0 ± 9.0</td><td valign="top" align="center" rowspan="1" colspan="1">–</td><td valign="top" align="center" rowspan="1" colspan="1">–</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Ca<sup>2+</sup> (mmol/L)</td><td valign="top" align="center" rowspan="1" colspan="1">2.1 ± 0.3</td><td valign="top" align="center" rowspan="1" colspan="1">–</td><td valign="top" align="center" rowspan="1" colspan="1">–</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">K<sup>+</sup> (mmol/L)</td><td valign="top" align="center" rowspan="1" colspan="1">4.5 ± 0.8</td><td valign="top" align="center" rowspan="1" colspan="1">–</td><td valign="top" align="center" rowspan="1" colspan="1">–</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Na<sup>+</sup> (mmo/L)</td><td valign="top" align="center" rowspan="1" colspan="1">139.3 ± 3.2</td><td valign="top" align="center" rowspan="1" colspan="1">–</td><td valign="top" align="center" rowspan="1" colspan="1">–</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Hemoglobin (g/L)</td><td valign="top" align="center" rowspan="1" colspan="1">92.7 ± 18.9</td><td valign="top" align="center" rowspan="1" colspan="1">–</td><td valign="top" align="center" rowspan="1" colspan="1">–</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Hematocrit</td><td valign="top" align="center" rowspan="1" colspan="1">29.2 ± 6.0</td><td valign="top" align="center" rowspan="1" colspan="1">–</td><td valign="top" align="center" rowspan="1" colspan="1">–</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Cholesterol (mmol/L)</td><td valign="top" align="center" rowspan="1" colspan="1">4.8 ± 2.2</td><td valign="top" align="center" rowspan="1" colspan="1">–</td><td valign="top" align="center" rowspan="1" colspan="1">–</td></tr></tbody></table><table-wrap-foot><p><italic>Values are represented as the mean ± SD</italic>.</p><p><italic>ESRD, end-stage renal disease</italic>.</p><fn id="TN1"><label>a</label><p><italic>The p-value was obtained by Chi-square test</italic>.</p></fn><fn id="TN2"><label>b</label><p><italic>The p-value was obtained by two-sided two-sample t-test</italic>.</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Demographic and Clinical Data of the Two Study Groups.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left">Variable</th><th valign="top" align="center">ESRD patients</th><th valign="top" align="center">Healthy controls</th><th valign="top" align="center">p-value</th></tr><tr><th/><th valign="top" align="center">(n = 32)</th><th valign="top" align="center">(n = 45)</th><th/></tr></thead><tbody><tr><td valign="top" align="left">Age (years)</td><td valign="top" align="center">44.4 ± 15.0</td><td valign="top" align="center">38.7 ± 13.1</td><td valign="top" align="center">0.080???</td></tr><tr><td valign="top" align="left">Sex (male/female)</td><td valign="top" align="center">17/15</td><td valign="top" align="center">23/22</td><td valign="top" align="center">0.862???</td></tr><tr><td valign="top" align="left">Education (years)</td><td valign="top" align="center">12.3 ± 2.7</td><td valign="top" align="center">12.9 ± 3.4</td><td valign="top" align="center">0.404???</td></tr><tr><td valign="top" align="left">Dialysis duration (month)</td><td valign="top" align="center">12.3 ± 12.2</td><td valign="top" align="center">–</td><td valign="top" align="center">–</td></tr><tr><td valign="top" align="left">creatinine (μmol/L)</td><td valign="top" align="center">642.3 ± 332.6</td><td valign="top" align="center">–</td><td valign="top" align="center">–</td></tr><tr><td valign="top" align="left">Urea (mmol/L)</td><td valign="top" align="center">22.0 ± 9.0</td><td valign="top" align="center">–</td><td valign="top" align="center">–</td></tr><tr><td valign="top" align="left">Ca2+ (mmol/L)</td><td valign="top" align="center">2.1 ± 0.3</td><td valign="top" align="center">–</td><td valign="top" align="center">–</td></tr><tr><td valign="top" align="left">K+ (mmol/L)</td><td valign="top" align="center">4.5 ± 0.8</td><td valign="top" align="center">–</td><td valign="top" align="center">–</td></tr><tr><td valign="top" align="left">Na+ (mmo/L)</td><td valign="top" align="center">139.3 ± 3.2</td><td valign="top" align="center">–</td><td valign="top" align="center">–</td></tr><tr><td valign="top" align="left">Hemoglobin (g/L)</td><td valign="top" align="center">92.7 ± 18.9</td><td valign="top" align="center">–</td><td valign="top" align="center">–</td></tr><tr><td valign="top" align="left">Hematocrit</td><td valign="top" align="center">29.2 ± 6.0</td><td valign="top" align="center">–</td><td valign="top" align="center">–</td></tr><tr><td valign="top" align="left">Cholesterol (mmol/L)</td><td valign="top" align="center">4.8 ± 2.2</td><td valign="top" align="center">–</td><td valign="top" align="center">–</td></tr></tbody></table></div>Values are represented as the mean ± SD.ESRD, end-stage renal disease.aThe p-value was obtained by Chi-square test.bThe p-value was obtained by two-sided two-sample t-test.</transformed-table></extracted-table><extracted-table><table-id>T2</table-id><table-label>Table 2</table-label><table-caption>Regions showing significantly decreased pairwise FC in patients with ESRD compared with HCs.</table-caption><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="T2" position="float"><label>Table 2</label><caption><p>Regions showing significantly decreased pairwise FC in patients with ESRD compared with HCs.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><bold>ROI region</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>Connected brain ROI region</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold><italic>t</italic>-value</bold></th></tr></thead><tbody><tr><td valign="top" align="left" colspan="3" rowspan="1">ESRD vs. HCs</td></tr><tr><td valign="top" align="left" colspan="3" rowspan="1">NBS correction (<italic>p</italic> &lt; 0.05)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">PCC</td><td valign="top" align="center" rowspan="1" colspan="1">aMPFC</td><td valign="top" align="center" rowspan="1" colspan="1">−2.029</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">pIPL</td><td valign="top" align="center" rowspan="1" colspan="1">−3.040</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">Rsp</td><td valign="top" align="center" rowspan="1" colspan="1">−2.205</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">aMPFC</td><td valign="top" align="center" rowspan="1" colspan="1">dMPFC</td><td valign="top" align="center" rowspan="1" colspan="1">−2.191</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">TPJ</td><td valign="top" align="center" rowspan="1" colspan="1">−2.058</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">Rsp</td><td valign="top" align="center" rowspan="1" colspan="1">−3.387</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">dMPFC</td><td valign="top" align="center" rowspan="1" colspan="1">TPJ</td><td valign="top" align="center" rowspan="1" colspan="1">−3.040</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">pIPL</td><td valign="top" align="center" rowspan="1" colspan="1">Rsp</td><td valign="top" align="center" rowspan="1" colspan="1">−2.329</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">PHC</td><td valign="top" align="center" rowspan="1" colspan="1">−2.559</td></tr></tbody></table><table-wrap-foot><p><italic>FC, functional connectivity; ESRD, end-stage renal disease; HCs, healthy controls; NBS, network-based statistic; PCC, posterior cingulate cortex; aMPFC, anterior medial prefrontal cortex; dMPFC, dorsal medial prefrontal cortex; TPJ, temporal parietal junction; Rsp, retrosplenial cortex; pIPL, posterior inferior parietal lobule; PHC, parahippocampal cortex</italic>.</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 2<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Regions showing significantly decreased pairwise FC in patients with ESRD compared with HCs.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left">ROI region</th><th valign="top" align="center">Connected brain ROI region</th><th valign="top" align="center">t-value</th></tr></thead><tbody><tr><td valign="top" align="left" colspan="3">ESRD vs. HCs</td></tr><tr><td valign="top" align="left" colspan="3">NBS correction (p &lt; 0.05)</td></tr><tr><td valign="top" align="left">PCC</td><td valign="top" align="center">aMPFC</td><td valign="top" align="center">−2.029</td></tr><tr><td/><td valign="top" align="center">pIPL</td><td valign="top" align="center">−3.040</td></tr><tr><td/><td valign="top" align="center">Rsp</td><td valign="top" align="center">−2.205</td></tr><tr><td valign="top" align="left">aMPFC</td><td valign="top" align="center">dMPFC</td><td valign="top" align="center">−2.191</td></tr><tr><td/><td valign="top" align="center">TPJ</td><td valign="top" align="center">−2.058</td></tr><tr><td/><td valign="top" align="center">Rsp</td><td valign="top" align="center">−3.387</td></tr><tr><td valign="top" align="left">dMPFC</td><td valign="top" align="center">TPJ</td><td valign="top" align="center">−3.040</td></tr><tr><td valign="top" align="left">pIPL</td><td valign="top" align="center">Rsp</td><td valign="top" align="center">−2.329</td></tr><tr><td/><td valign="top" align="center">PHC</td><td valign="top" align="center">−2.559</td></tr></tbody></table></div>FC, functional connectivity; ESRD, end-stage renal disease; HCs, healthy controls; NBS, network-based statistic; PCC, posterior cingulate cortex; aMPFC, anterior medial prefrontal cortex; dMPFC, dorsal medial prefrontal cortex; TPJ, temporal parietal junction; Rsp, retrosplenial cortex; pIPL, posterior inferior parietal lobule; PHC, parahippocampal cortex.</transformed-table></extracted-table><extracted-table><table-id>T3</table-id><table-label>Table 3</table-label><table-caption>Regions showing significantly decreased voxelwise FC in patients with ESRD compared with HCs.</table-caption><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="T3" position="float"><label>Table 3</label><caption><p>Regions showing significantly decreased voxelwise FC in patients with ESRD compared with HCs.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><bold>ROI region</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Connected brain region</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Side</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>Brodmann area</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>Cluster size</bold></th><th valign="top" align="center" colspan="3" style="border-bottom: thin solid #000000;" rowspan="1"><bold>MNI coordinates (mm)</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold><italic>t</italic>-value</bold></th></tr><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th valign="top" align="center" rowspan="1" colspan="1"><bold>X</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>Y</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>Z</bold></th><th rowspan="1" colspan="1"/></tr></thead><tbody><tr><td valign="top" align="left" colspan="9" rowspan="1"><bold>ESRD vs. HCs (GRF correction, voxel-level threshold</bold><italic><bold>p</bold></italic><bold>&lt;</bold><bold>0.001, cluster-level threshold</bold><italic><bold>p</bold></italic><bold>&lt;</bold><bold>0.01, 2-tailed)</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">PCC</td><td valign="top" align="left" rowspan="1" colspan="1">aMPFC</td><td valign="top" align="left" rowspan="1" colspan="1">L/R</td><td valign="top" align="center" rowspan="1" colspan="1">10</td><td valign="top" align="center" rowspan="1" colspan="1">110</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">63</td><td valign="top" align="center" rowspan="1" colspan="1">15</td><td valign="top" align="center" rowspan="1" colspan="1">−5.1763</td></tr><tr><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Pcu</td><td valign="top" align="left" rowspan="1" colspan="1">L/R</td><td valign="top" align="center" rowspan="1" colspan="1">23</td><td valign="top" align="center" rowspan="1" colspan="1">129</td><td valign="top" align="center" rowspan="1" colspan="1">−6</td><td valign="top" align="center" rowspan="1" colspan="1">−63</td><td valign="top" align="center" rowspan="1" colspan="1">24</td><td valign="top" align="center" rowspan="1" colspan="1">−5.5477</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">aMPFC</td><td valign="top" align="left" rowspan="1" colspan="1">PCC</td><td valign="top" align="left" rowspan="1" colspan="1">L/R</td><td valign="top" align="center" rowspan="1" colspan="1">30</td><td valign="top" align="center" rowspan="1" colspan="1">92</td><td valign="top" align="center" rowspan="1" colspan="1">−6</td><td valign="top" align="center" rowspan="1" colspan="1">−42</td><td valign="top" align="center" rowspan="1" colspan="1">15</td><td valign="top" align="center" rowspan="1" colspan="1">−4.4341</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">dMPFC</td><td valign="top" align="left" rowspan="1" colspan="1">aMPFC</td><td valign="top" align="left" rowspan="1" colspan="1">L/R</td><td valign="top" align="center" rowspan="1" colspan="1">10</td><td valign="top" align="center" rowspan="1" colspan="1">86</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">60</td><td valign="top" align="center" rowspan="1" colspan="1">15</td><td valign="top" align="center" rowspan="1" colspan="1">−5.2356</td></tr></tbody></table><table-wrap-foot><p><italic>FC, functional connectivity; ESRD, end-stage renal disease; HCs, healthy controls; MNI, Montreal Neurological Institute; GRF, Gaussian random field; PCC, posterior cingulate cortex; aMPFC, anterior medial prefrontal cortex; Pcu, precuneus</italic>.</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 3<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Regions showing significantly decreased voxelwise FC in patients with ESRD compared with HCs.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left">ROI region</th><th valign="top" align="left">Connected brain region</th><th valign="top" align="left">Side</th><th valign="top" align="center">Brodmann area</th><th valign="top" align="center">Cluster size</th><th valign="top" align="center" colspan="3" style="border-bottom: thin solid #000000;">MNI coordinates (mm)</th><th valign="top" align="center">t-value</th></tr><tr><th/><th/><th/><th/><th/><th valign="top" align="center">X</th><th valign="top" align="center">Y</th><th valign="top" align="center">Z</th><th/></tr></thead><tbody><tr><td valign="top" align="left" colspan="9">ESRD vs. HCs (GRF correction, voxel-level thresholdp&lt;0.001, cluster-level thresholdp&lt;0.01, 2-tailed)</td></tr><tr><td valign="top" align="left">PCC</td><td valign="top" align="left">aMPFC</td><td valign="top" align="left">L/R</td><td valign="top" align="center">10</td><td valign="top" align="center">110</td><td valign="top" align="center">0</td><td valign="top" align="center">63</td><td valign="top" align="center">15</td><td valign="top" align="center">−5.1763</td></tr><tr><td/><td valign="top" align="left">Pcu</td><td valign="top" align="left">L/R</td><td valign="top" align="center">23</td><td valign="top" align="center">129</td><td valign="top" align="center">−6</td><td valign="top" align="center">−63</td><td valign="top" align="center">24</td><td valign="top" align="center">−5.5477</td></tr><tr><td valign="top" align="left">aMPFC</td><td valign="top" align="left">PCC</td><td valign="top" align="left">L/R</td><td valign="top" align="center">30</td><td valign="top" align="center">92</td><td valign="top" align="center">−6</td><td valign="top" align="center">−42</td><td valign="top" align="center">15</td><td valign="top" align="center">−4.4341</td></tr><tr><td valign="top" align="left">dMPFC</td><td valign="top" align="left">aMPFC</td><td valign="top" align="left">L/R</td><td valign="top" align="center">10</td><td valign="top" align="center">86</td><td valign="top" align="center">0</td><td valign="top" align="center">60</td><td valign="top" align="center">15</td><td valign="top" align="center">−5.2356</td></tr></tbody></table></div>FC, functional connectivity; ESRD, end-stage renal disease; HCs, healthy controls; MNI, Montreal Neurological Institute; GRF, Gaussian random field; PCC, posterior cingulate cortex; aMPFC, anterior medial prefrontal cortex; Pcu, precuneus.</transformed-table></extracted-table></extracted-tables-set>